Skip to main content

Table 2 Patient Characteristics.

From: Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer

Characteristics

n

Age (years)

 

   Median

64

   Range

49–77

Gender

 

   Male

9

   Female

9

ECOG performance status

 

   0

5

   1

12

   2

1

   Not Reported

3

Tumor Type

 

   NSCLC

15

   SCLC

3

Previous Chemotherapy Regimens

 

   1

5

   2

2

   3

5

   ≥4

6

Prior Radiotherapy

6